OR WAIT null SECS
June 13, 2024
Technological advances are aiding manufacturers to streamline aseptic processes and improve time-to-market.
June 08, 2024
CGT manufacturing processes need automation as well as standardization, according to Lonza’s Joe Garrity and Jerry Jiang.
June 07, 2024
Raphael Townshend, founder and CEO of Atomic AI, speaks on AI’s usefulness in characterizing molecular structure and advancing molecular engineering.
June 06, 2024
Chemify founder and CEO, Lee Cronin gives insight into the combination of digital chemistry, robotics, and AI in the drug discovery process.
June 03, 2024
Improved efficiencies and reduced costs are clear advantages of automating drug manufacturing processes.
May 31, 2024
Cellular Origins will apply its robotic platform to establish automated CGT manufacturing at CGT Catapult’s manufacturing innovation center in Stevenage, UK.
May 05, 2024
Digital transformation is allowing for better handling, analysis, and protection of vast data collection.
April 23, 2024
Under the agreement, Bristol Myers Squibb will have access to Cellares’ fully automated cell therapy manufacturing platform, Cell Shuttle, to manufacture select CAR-T cell therapies.
April 03, 2024
NGS abbreviates drug discovery timelines.
February 02, 2024
SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.